CD4 in Combination With CHOP in Treating Non-cutaneous Peripheral TCell Lymphoma

Phase 2

Terminated

• Conditions: T-cell Lymphoma
• Interventions: Biological: CHOP + CD4; Drug: CHOP

• Registration Number: NCT00893516
• Lead Sponsor: Emergent BioSolutions

Brief Summary

Evaluation of CD4 in combination with CHO chemotherapy in subjects with nodal involvement of non cutaneous Tcell lymphoma.

Detailed Description

Not available

Study Timeline

• Study Start: 2007-05
• Primary Completion: 2008-10
• Study Completion: 2008-12
• Study First Submitted: 2009-05-05
• Study First Submitted QC: 2009-05-05
• Study First Posted: 2009-05-06
• Results First Submitted: 2021-03-30
• Results First Submitted QC: 2021-03-30
• Results First Posted: 2021-04-21
• Status Verified: 2024-03
• Last Update Submitted: 2024-03-14
• Last Update Posted: 2024-04-09

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 5

Inclusion Criteria

• study is closed to enrollment

Exclusion Criteria

• study is closed to enrollment

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
1	CHOP + CD4	CHOP chemo therapy + CD4 therapy
2	CHOP	CHOP chemotherapy

Primary Outcome Measures

Name	Time	Method
Primary Outcome Unavailable		All efforts to obtain data have been exhausted, therefore we have no data available to report.